Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Foresite Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
JadebiosciencesFounded 2024 • 201-500 employees • 6 roles
On a mission to transform the future of autoimmune care. Developing innovative therapies with the potential to redefine the standard of…
Odyssey is on a mission to transform the standard of care for patients affected by autoimmune and inflammatory conditions.
IndomoFounded 2021 • 51-200 employees
A clinical-stage therapeutics company, Indomo pairs proven medicines with novel delivery systems to create fast-acting, self-administered…
Committed to developing high-impact and differentiated therapies, with a focus on building a robust autoimmune disease and cancer pipeline…
Quercis Pharma develops Kinisoquin™, a first-in-class oral PDI inhibitor in Phase 3 for the prevention of cancer-associated thrombosis…
Octagon TherapeuticsVenture round $11M · 2 yr ago • Founded 2016 • 11-50 employees
A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the…

Overview

Pioneering a World Free from Complement Disease. The complement system is complex and implicated in a large number of autoimmune and inflammatory conditions across hematology, nephrology, neurology, dermatology, ophthalmology and many other disease areas.